• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    AVEO Pharmaceuticals, Inc. (AVEO)

    -NasdaqGS
    0.93 Down 0.04(3.63%) Apr 29, 3:59PM EDT
    Prev Close:0.97
    Open:0.96
    Bid:0.90 x 1000
    Ask:0.99 x 3200
    1y Target Est:3.00
    Beta:0.955862
    Earnings Date:May 5 - May 9 (Est.)
    Day's Range:0.92 - 0.98
    52wk Range:0.82 - 3.50
    Volume:323,945
    Avg Vol (3m):218,524
    Market Cap:54.11M
    P/E (ttm):N/A
    EPS (ttm):-0.41
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AVEO

    Comparison

    Symbol% ChgMkt Cap
    AVEODown 3.63%54.11M
    PFEDown 0.61%202.54B
    AMGNDown 1.41%118.73B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.61
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.55
    Quarterly EPS Est (Mar-16) :-0.12
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted therapies for patients with cancer and related diseases. The company’s pipeline of product candidates include Tivozanib, an tyrosine kinase inhibitor for various vascu... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback